Correlation Between Ventyx Biosciences and Cytokinetics

Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ventyx Biosciences and Cytokinetics, you can compare the effects of market volatilities on Ventyx Biosciences and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Cytokinetics.

Diversification Opportunities for Ventyx Biosciences and Cytokinetics

0.32

Correlation Coefficient

Ventyx Biosciences  Cytokinetics

Weak diversification

The 3 months correlation between Ventyx and Cytokinetics is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Cytokinetics go up and down completely randomly.

Pair Corralation between Ventyx Biosciences and Cytokinetics

Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Cytokinetics. In addition to that, Ventyx Biosciences is 1.49 times more volatile than Cytokinetics. It trades about -0.03 of its total potential returns per unit of risk. Cytokinetics is currently generating about 0.04 per unit of volatility. If you would invest  3,884  in Cytokinetics on August 31, 2024 and sell it today you would earn a total of  1,338  from holding Cytokinetics or generate 34.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ventyx Biosciences  vs.  Cytokinetics

Ventyx Biosciences

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ventyx Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Cytokinetics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Cytokinetics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Ventyx Biosciences and Cytokinetics

The main advantage of trading using opposite Ventyx Biosciences and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.

The idea behind Ventyx Biosciences and Cytokinetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..